[1] 许春伶, 赵伟秦, 李继海, 等. 抗 NMDA 受体脑炎一例病例报告[C]// 中华医学会神经病学分会. 中华医学会第十三次全国神经病学学术会议论文汇编. (2010-9-23)[2014-7-15]. http: //www. cnki. net/KCMS/detail/detail. spx?QueryID=5&CurRec=5&recid=&filename=ZHYX201009001149&dbname=CPFD0911&dbcode=CPFD&pr=&urlid=&yx=&v=MDczNzZaZW9MQlJOS3
VoZGhuajk4VG5qcXF4ZEVlTU9VS3JpZlp1SnVGeW5qVUwvTUtWc1VQeVhTZHJHNEg5SE1wbzlG
[2] 韩太真, 李延海. NMDA 受体的结构与药理学特性[J]. 心理科学进展, 2008, 16(3): 464-474.
[3] DALMAU J, TüZüN E, WU H Y, et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma[J]. Ann Neurol, 2007, 61(1): 25-36.
[4] 乔娜娜. 儿童抗 N-甲基-D-天冬氨酸受体抗体脑炎[J]. 国际儿科学杂志, 2013, 40(5): 481-485.
[5] TüZüN E, ZHOU L, BAEHRING J M, et al. Evidence for antibody-mediated pathogenesis in anti-NMDAR encephalitis associated with ovarian teratoma[J]. Acta Neuropathol, 2009, 118(6): 737-743.
[6] HUGHES E G, PENG X, GLEICHMAN A J, et al. Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis[J]. Neurosci, 2010, 30(17): 5866-5875.
[7] LIZUKA T, SAKAI F, IDE T, et al. Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal[J]. Neurology, 2008, 70(7): 504-511．
[8] 刘美云, 谢琰臣, 李继梅. 抗 NMDA 受体脑炎[J]. 中国神经免疫学和神经病学杂志, 2010, 17(6): 449-451.
[9] VILENSKY J A, DUVOISIN R C. Response to immunotherapy in a 20-month-old boy with anti-NMDA receptor encephalitis[J]. Neurology, 2011, 76(1): 105.
[10] DALMAU J, GLEICHMAN A J, HUGHES E G, et al. Anti-NMDA receptor encephalitis: case series and analysis of the effects of antibodies[J]. Lance Neurol, 2008, 7(12): 1091-1098.
[11] GüNTHER A, BRODOEHL S, WITTE O W, et al. Atypical posthypoxic MRI changes in hypermetabolic regions in anti-NMDA-receptor encephalitis[J]. Neurology, 2012, 79(7): 720-721.
[12] ARMANGUE T, TITULAER M J, MáLAGA I, et al. Pediatric anti-N-methyl-D-aspartate receptor encephalitis-clinical analysis and novel findings in a series of 20 patients[J]. Pediatr, 2013, 162(4): 850-856.
[13] DALMAU J, LANCASTER E, MARTINEZ-HERNANDEZ E, et al. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis[J]. Lancet Neurol, 2011,10(1): 63-74.
|
